Takeo Edamatsu Selected Research

KRH 1636

4/2003

A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeo Edamatsu Research Topics

Disease

3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2013 - 09/2011
3	Leukemia 07/2013 - 09/2011
2	Chronic Renal Insufficiency 01/2018 - 08/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2012 - 09/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2016
1	Inflammation (Inflammations) 08/2016
1	Colonic Neoplasms (Colon Cancer) 12/2013
1	Neoplasms (Cancer) 12/2013
1	Stomach Neoplasms (Stomach Cancer) 12/2013
1	Myositis (Idiopathic Inflammatory Myopathies) 04/2006
1	Infections 04/2003

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2011
4	polysaccharide-KIBA 12/2013 - 09/2011
2	p38 Mitogen-Activated Protein KinasesIBA 07/2013 - 07/2012
2	streptococcal polysaccharide type III group BIBA 07/2012 - 09/2011
1	Sulfates (Sulfates, Inorganic)IBA 01/2018
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2016
1	IndicanIBA 08/2016
1	LigandsIBA 08/2016
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 08/2016
1	Fluorouracil (Carac)FDA LinkGeneric 12/2013
1	doxifluridineIBA 12/2013
1	Thymidine PhosphorylaseIBA 12/2013
1	Thymidylate SynthaseIBA 12/2013
1	TransferasesIBA 12/2013
1	CytokinesIBA 12/2013
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 12/2013
1	EnzymesIBA 12/2013
1	Messenger RNA (mRNA)IBA 12/2013
1	Ligases (Synthetase)IBA 04/2006
1	Chemokine ReceptorsIBA 04/2006
1	AutoantigensIBA 04/2006
1	RNA (Ribonucleic Acid)IBA 04/2006
1	KRH 1636IBA 04/2003

Therapy/Procedure

2	Therapeutics 07/2012 - 09/2011